Review



cov np 229e  (EastCoast Bio)


Bioz Verified Symbol EastCoast Bio is a verified supplier
Bioz Manufacturer Symbol EastCoast Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    EastCoast Bio cov np 229e
    Cov Np 229e, supplied by EastCoast Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Coronavirus+(CoV-NP+229E%3B+Full+Length)+Antigen%2C+Recombinant+%3E90%25/pmc08117401-38-13-18
    Average 92 stars, based on 1 article reviews
    cov np 229e - by Bioz Stars, 2026-10
    92/100 stars

    Images

    Related Articles

    other:

    Article Title: Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein
    Article Snippet: SARS-CoV-2 N (b), SARS-CoV NP, CoV-NP HKU1, CoV-NP OC43, MERS-CoV NP, CoV-NP-NL63, and CoV-NP 229E were obtained from East Coast Bio (North Berwick, ME, USA).

    Article Title: Single-Domain Antibodies for the Detection of SARS-CoV-2 Nucleocapsid Protein
    Article Snippet: SARS-CoV-2 N (b), SARS-CoV NP, CoV-NP HKU1, CoVNP OC43, MERS-CoV NP, CoV-NP-NL63, and CoV-NP 229E were obtained from East Coast Bio (North Berwick, ME, USA).



    Similar Products

    95
    Sino Biological t62 229e cov np antibody sino biological cas
    T62 229e Cov Np Antibody Sino Biological Cas, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Human+coronavirus+(HCoV-OC43)+Nucleocapsid+Antibody%2C+Rabbit+PAb%2C+Antigen+Affinity+Purified/pm41650964-140-26-30
    Average 95 stars, based on 1 article reviews
    t62 229e cov np antibody sino biological cas - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    92
    Sino Biological cov 229e
    Clinical and serological data of patient samples analysed for the relation of antibody levels against MOG, SARS-CoV-2 and other common coronaviruses
    Cov 229e, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Human+coronavirus+229E+(HCoV-229E)+Nucleocapsid+%2F+NP+Gene+ORF+cDNA+clone+expression+plasmid/pmc10994262-98-19-22
    Average 92 stars, based on 1 article reviews
    cov 229e - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Sino Biological human cov 229e sa aak32191 1 b sino biological
    Clinical and serological data of patient samples analysed for the relation of antibody levels against MOG, SARS-CoV-2 and other common coronaviruses
    Human Cov 229e Sa Aak32191 1 B Sino Biological, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Human+coronavirus+229E+(HCoV-229E)+Nucleocapsid+%2F+NP+Gene+ORF+cDNA+clone+expression+plasmid/pmc09461429__42003_2022_3866_MOESM1_ESM-6-304-308
    Average 92 stars, based on 1 article reviews
    human cov 229e sa aak32191 1 b sino biological - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    95
    Sino Biological hcov 229e nucleoprotein rabbit polyclonal antibody
    Clinical and serological data of patient samples analysed for the relation of antibody levels against MOG, SARS-CoV-2 and other common coronaviruses
    Hcov 229e Nucleoprotein Rabbit Polyclonal Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/MERS-CoV+Nucleoprotein+%2F+NP+Antibody%2C+Rabbit+PAb/pm36823196-160-11-16
    Average 95 stars, based on 1 article reviews
    hcov 229e nucleoprotein rabbit polyclonal antibody - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    92
    Sino Biological 229e cov
    Specificity profiling of rfhSP-D using the HCoV protein microarray. The rfhSP-D was purified and incubated with the HCoV protein microarray with calcium supplementation. (A) The spike proteins from <t>SARS-CoV-2,</t> MERS-CoV, SARS-CoV, HKU1-CoV, <t>229E-CoV,</t> NL63-CoV, and OC43-CoV showed significant binding signals compared with BSA. Data were analyzed by two-way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, compared with BSA. (B) The 875 ng of rfhSP-D showed significant bindings to the spike proteins from all human coronaviruses. Data were analyzed by One-Way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with BSA.
    229e Cov, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Human+coronavirus+229E+(HCoV-229E)+Nucleocapsid+%2F+NP+Gene+ORF+cDNA+clone+expression+plasmid/pmc08146142-32-28-48
    Average 92 stars, based on 1 article reviews
    229e cov - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    EastCoast Bio cov np 229e
    Specificity profiling of rfhSP-D using the HCoV protein microarray. The rfhSP-D was purified and incubated with the HCoV protein microarray with calcium supplementation. (A) The spike proteins from <t>SARS-CoV-2,</t> MERS-CoV, SARS-CoV, HKU1-CoV, <t>229E-CoV,</t> NL63-CoV, and OC43-CoV showed significant binding signals compared with BSA. Data were analyzed by two-way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, compared with BSA. (B) The 875 ng of rfhSP-D showed significant bindings to the spike proteins from all human coronaviruses. Data were analyzed by One-Way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with BSA.
    Cov Np 229e, supplied by EastCoast Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Coronavirus+(CoV-NP+229E%3B+Full+Length)+Antigen%2C+Recombinant+%3E90%25/pmc08117401-38-13-18
    Average 92 stars, based on 1 article reviews
    cov np 229e - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    92
    Sino Biological sars cov spike gene dr wenlin huang genbank aap13567 1 mers cov spike gene dr shibo jiang genbank afs88936 1 hcov 229e spike gene orf cdna
    Specificity profiling of rfhSP-D using the HCoV protein microarray. The rfhSP-D was purified and incubated with the HCoV protein microarray with calcium supplementation. (A) The spike proteins from <t>SARS-CoV-2,</t> MERS-CoV, SARS-CoV, HKU1-CoV, <t>229E-CoV,</t> NL63-CoV, and OC43-CoV showed significant binding signals compared with BSA. Data were analyzed by two-way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, compared with BSA. (B) The 875 ng of rfhSP-D showed significant bindings to the spike proteins from all human coronaviruses. Data were analyzed by One-Way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with BSA.
    Sars Cov Spike Gene Dr Wenlin Huang Genbank Aap13567 1 Mers Cov Spike Gene Dr Shibo Jiang Genbank Afs88936 1 Hcov 229e Spike Gene Orf Cdna, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cov+np+229e/Human+coronavirus+229E+(HCoV-229E)+Nucleocapsid+NP+Gene+ORF+cDNA+clone+expression+plasmid/pmc07687490__mmc2-357-133-157
    Average 92 stars, based on 1 article reviews
    sars cov spike gene dr wenlin huang genbank aap13567 1 mers cov spike gene dr shibo jiang genbank afs88936 1 hcov 229e spike gene orf cdna - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    Image Search Results


    Clinical and serological data of patient samples analysed for the relation of antibody levels against MOG, SARS-CoV-2 and other common coronaviruses

    Journal: Brain Communications

    Article Title: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?

    doi: 10.1093/braincomms/fcae106

    Figure Lengend Snippet: Clinical and serological data of patient samples analysed for the relation of antibody levels against MOG, SARS-CoV-2 and other common coronaviruses

    Article Snippet: Additionally, antibody analysis of selected sera and/or purified IgG fractions were performed against the following antigens: SARS-CoV-2-N (Invitrogen RP87665), CoV-229E (HCoV-229E NP, Sino Biologicals 40640), CoV-OC43 (HCoV-OC43 NP, Sino Biologicals 40643), CoV-HKU1 (HCoV-HKU1 NP, Sino Biologicals 40642) and overlapping 20mer peptides of SARS-CoV-2 N 1-242 (synthetized by Genscript, Uniprot P0DTC9).

    Techniques: Infection

    Antibody reactivity against SARS-CoV-2 and common coronaviruses in samples from people with SARS-CoV-2 infection (COVID-19), SARS-CoV-2 vaccination or negative/naïve for SARS-CoV-2, as measured by ProcartaPlex assay . Total immunoglobulin (Ig) antibodies against ( A ) SARS-CoV-2 N ( P < 0.001, ε 2 = 0.697), ( B ) RBD ( P < 0.001, ε 2 = 0.725), ( C ) S(trimer) ( P < 0.001, ε 2 = 0.732) and ( D ) S1 proteins ( P < 0.001 ε 2 = 0.737); and ( E ) CoV-229E ( P = 0.007 ε 2 = 0.128), ( F ) CoV-HKU1 ( P = 0.008, ε 2 = 0.126), ( G ) CoV-OC43 ( P = 0.330 ε 2 = 0.049) and ( H ) CoV-NL63 ( P = 0.090, ε 2 = 0.079) were measured using the Coronavirus Ig Total Human 11-Plex ProcartaPlex™ Panel (Invitrogen, EPX110-16000-901). Significance of group differences was tested using the Kruskal-Wallis test and effect sizes ε 2 and P -values are indicated above. Only group differences (analysed Dunn’s multiple comparison test) within each subgroup (SARS-CoV-2 infection, SARS-CoV-2 vaccination or negative/naïve) are shown, asterisks indicate a significant difference between groups after correction for multiple comparisons (21) using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. Data are shown as boxplots (boxes represent 25th to 75th percentiles with medians indicated by the horizontal lines, whiskers represent minimum to maximum) with individual data points (circles). CNS, other demyelinating disease; CoV, coronavirus; Ig, total immunoglobulin; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; MOG, myelin oligodendrocyte glycoprotein; MOGAD, MOG antibody-associated demyelinating disease; N, SARS-CoV-2 nucleocapsid protein; noCNS, no neurological symptoms; RBD, receptor binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; S, SARS-CoV-2 spike protein; S1, S1 subunit SARS-CoV-2 spike protein; S(trimer), trimer of SARS-CoV-2 spike protein; U/ml, U/ml.

    Journal: Brain Communications

    Article Title: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?

    doi: 10.1093/braincomms/fcae106

    Figure Lengend Snippet: Antibody reactivity against SARS-CoV-2 and common coronaviruses in samples from people with SARS-CoV-2 infection (COVID-19), SARS-CoV-2 vaccination or negative/naïve for SARS-CoV-2, as measured by ProcartaPlex assay . Total immunoglobulin (Ig) antibodies against ( A ) SARS-CoV-2 N ( P < 0.001, ε 2 = 0.697), ( B ) RBD ( P < 0.001, ε 2 = 0.725), ( C ) S(trimer) ( P < 0.001, ε 2 = 0.732) and ( D ) S1 proteins ( P < 0.001 ε 2 = 0.737); and ( E ) CoV-229E ( P = 0.007 ε 2 = 0.128), ( F ) CoV-HKU1 ( P = 0.008, ε 2 = 0.126), ( G ) CoV-OC43 ( P = 0.330 ε 2 = 0.049) and ( H ) CoV-NL63 ( P = 0.090, ε 2 = 0.079) were measured using the Coronavirus Ig Total Human 11-Plex ProcartaPlex™ Panel (Invitrogen, EPX110-16000-901). Significance of group differences was tested using the Kruskal-Wallis test and effect sizes ε 2 and P -values are indicated above. Only group differences (analysed Dunn’s multiple comparison test) within each subgroup (SARS-CoV-2 infection, SARS-CoV-2 vaccination or negative/naïve) are shown, asterisks indicate a significant difference between groups after correction for multiple comparisons (21) using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli. Data are shown as boxplots (boxes represent 25th to 75th percentiles with medians indicated by the horizontal lines, whiskers represent minimum to maximum) with individual data points (circles). CNS, other demyelinating disease; CoV, coronavirus; Ig, total immunoglobulin; IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M; MOG, myelin oligodendrocyte glycoprotein; MOGAD, MOG antibody-associated demyelinating disease; N, SARS-CoV-2 nucleocapsid protein; noCNS, no neurological symptoms; RBD, receptor binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; S, SARS-CoV-2 spike protein; S1, S1 subunit SARS-CoV-2 spike protein; S(trimer), trimer of SARS-CoV-2 spike protein; U/ml, U/ml.

    Article Snippet: Additionally, antibody analysis of selected sera and/or purified IgG fractions were performed against the following antigens: SARS-CoV-2-N (Invitrogen RP87665), CoV-229E (HCoV-229E NP, Sino Biologicals 40640), CoV-OC43 (HCoV-OC43 NP, Sino Biologicals 40643), CoV-HKU1 (HCoV-HKU1 NP, Sino Biologicals 40642) and overlapping 20mer peptides of SARS-CoV-2 N 1-242 (synthetized by Genscript, Uniprot P0DTC9).

    Techniques: Infection, Comparison, Binding Assay

    Relation of antibody reactivities against MOG, SARS-CoV-2 S and N proteins and common coronaviruses (CoV-229E, CoV-HKU1, CoV-OC43 and CoV-NL63) analysed by principal component analysis . ( A ) Scatter dot plot showing the loading scores of all antibodies analysed to visualize parameters responsible for clustering. ( B ) Principal component (PC) scores of all samples. A subgroup of samples with high MOG-IgG titres but low/negative antibody levels against SARS-CoV-2 and common coronaviruses is indicated by a circle and a grey arrow. ( C ) Heatmap of the quantitative results (standardized values of log-transformed antibody levels) according to their PC1 and PC2 scores. ( D ) Spearman correlation coefficients of MOG antibodies (IgG, IgA and IgM) with antibodies against SARS-CoV-2 and common coronaviruses. CNS, other demyelinating disease; CoV, coronavirus; IgA, immunoglobulin A; Ig, total immunoglobulin; IgG, immunoglobulin G; IgM, immunoglobulin M; MOG, myelin oligodendrocyte glycoprotein; MOGAD, MOG antibody-associated demyelinating disease; N, SARS-CoV-2 nucleocapsid protein; noCNS, no neurological symptoms; PC, principal component; RBD, receptor binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SARS-CoV-2 (−), SARS-CoV-2 antibody negative; SARS-CoV-2 (+), SARS-CoV-2 antibody positive; S, SARS-CoV-2 spike protein; S1, S1 subunit SARS-CoV-2 spike protein; S(trimer), trimer of SARS-CoV-2 spike protein.

    Journal: Brain Communications

    Article Title: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?

    doi: 10.1093/braincomms/fcae106

    Figure Lengend Snippet: Relation of antibody reactivities against MOG, SARS-CoV-2 S and N proteins and common coronaviruses (CoV-229E, CoV-HKU1, CoV-OC43 and CoV-NL63) analysed by principal component analysis . ( A ) Scatter dot plot showing the loading scores of all antibodies analysed to visualize parameters responsible for clustering. ( B ) Principal component (PC) scores of all samples. A subgroup of samples with high MOG-IgG titres but low/negative antibody levels against SARS-CoV-2 and common coronaviruses is indicated by a circle and a grey arrow. ( C ) Heatmap of the quantitative results (standardized values of log-transformed antibody levels) according to their PC1 and PC2 scores. ( D ) Spearman correlation coefficients of MOG antibodies (IgG, IgA and IgM) with antibodies against SARS-CoV-2 and common coronaviruses. CNS, other demyelinating disease; CoV, coronavirus; IgA, immunoglobulin A; Ig, total immunoglobulin; IgG, immunoglobulin G; IgM, immunoglobulin M; MOG, myelin oligodendrocyte glycoprotein; MOGAD, MOG antibody-associated demyelinating disease; N, SARS-CoV-2 nucleocapsid protein; noCNS, no neurological symptoms; PC, principal component; RBD, receptor binding domain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SARS-CoV-2 (−), SARS-CoV-2 antibody negative; SARS-CoV-2 (+), SARS-CoV-2 antibody positive; S, SARS-CoV-2 spike protein; S1, S1 subunit SARS-CoV-2 spike protein; S(trimer), trimer of SARS-CoV-2 spike protein.

    Article Snippet: Additionally, antibody analysis of selected sera and/or purified IgG fractions were performed against the following antigens: SARS-CoV-2-N (Invitrogen RP87665), CoV-229E (HCoV-229E NP, Sino Biologicals 40640), CoV-OC43 (HCoV-OC43 NP, Sino Biologicals 40643), CoV-HKU1 (HCoV-HKU1 NP, Sino Biologicals 40642) and overlapping 20mer peptides of SARS-CoV-2 N 1-242 (synthetized by Genscript, Uniprot P0DTC9).

    Techniques: Transformation Assay, Binding Assay

    Ordinal regression analysis for predictors for MOG antibody responses

    Journal: Brain Communications

    Article Title: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?

    doi: 10.1093/braincomms/fcae106

    Figure Lengend Snippet: Ordinal regression analysis for predictors for MOG antibody responses

    Article Snippet: Additionally, antibody analysis of selected sera and/or purified IgG fractions were performed against the following antigens: SARS-CoV-2-N (Invitrogen RP87665), CoV-229E (HCoV-229E NP, Sino Biologicals 40640), CoV-OC43 (HCoV-OC43 NP, Sino Biologicals 40643), CoV-HKU1 (HCoV-HKU1 NP, Sino Biologicals 40642) and overlapping 20mer peptides of SARS-CoV-2 N 1-242 (synthetized by Genscript, Uniprot P0DTC9).

    Techniques: Infection

    Specificity profiling of rfhSP-D using the HCoV protein microarray. The rfhSP-D was purified and incubated with the HCoV protein microarray with calcium supplementation. (A) The spike proteins from SARS-CoV-2, MERS-CoV, SARS-CoV, HKU1-CoV, 229E-CoV, NL63-CoV, and OC43-CoV showed significant binding signals compared with BSA. Data were analyzed by two-way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, compared with BSA. (B) The 875 ng of rfhSP-D showed significant bindings to the spike proteins from all human coronaviruses. Data were analyzed by One-Way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with BSA.

    Journal: Analytical Chemistry

    Article Title: Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis

    doi: 10.1021/acs.analchem.1c00614

    Figure Lengend Snippet: Specificity profiling of rfhSP-D using the HCoV protein microarray. The rfhSP-D was purified and incubated with the HCoV protein microarray with calcium supplementation. (A) The spike proteins from SARS-CoV-2, MERS-CoV, SARS-CoV, HKU1-CoV, 229E-CoV, NL63-CoV, and OC43-CoV showed significant binding signals compared with BSA. Data were analyzed by two-way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, compared with BSA. (B) The 875 ng of rfhSP-D showed significant bindings to the spike proteins from all human coronaviruses. Data were analyzed by One-Way ANOVA with multiple comparisons. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05, compared with BSA.

    Article Snippet: Twenty viral proteins, which consist of 10 spike proteins (both full and s1 domains); 7 nucleocapsid proteins from coronavirus that causes human diseases including MERS-CoV, SARS-CoV, SARS-CoV-2, HKU1-CoV, 229E-CoV, NL63-CoV, and OC43-CoV; and 3 HA proteins from popular influenza strains, e.g., H1N1, H3N2, and FluB, were purchased from Sino Biological.

    Techniques: Microarray, Purification, Incubation, Binding Assay